Bulldog Investors’s Starling Oncology STLN Stock Holding History

Bulldog Investors’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-307,288	Closed	-$3.05M	–	296
2021 Q3	$3.05M	Hold	307,288	–	–	0.87%	35
2021 Q2	$3.06M	Hold	307,288	–	–	0.81%	41
2021 Q1	$3.06M	Hold	307,288	–	–	0.9%	34
2020 Q4	$3.32M	Buy	+307,288	New	+$3.16M	1.22%	26

Other funds holding STLN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

AGM

Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Bulldog Investors's STLN Position: Q4 2021 in Review

Bulldog Investors sold out of Starling Oncology (STLN) in Q4 2021, closing a stake of 307,288 shares — an estimated $3.05M sold.

Bulldog Investors first reported a position in STLN in Q4 2020 and held it in 4 quarters. The position peaked at $3.32M in Q4 2020. 21 funds tracked by Wall St. Rank hold STLN as of Q4 2021.

Bulldog Investors reported no remaining Starling Oncology position as of Q4 2021 after selling out during the quarter.
Bulldog Investors sold 307,288 Starling Oncology shares in Q4 2021, an estimated $3.05M.
Bulldog Investors first reported a position in Starling Oncology in Q4 2020 and held it in 4 quarters.
Bulldog Investors's Starling Oncology position peaked at $3.32M in Q4 2020.
21 funds tracked by Wall St. Rank held Starling Oncology as of Q4 2021.

Based on Bulldog Investors's 13F filing for Q4 2021, filed 11 Feb 2022.